LMR Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $19M | Buy |
330,151
+325,150
| +6,502% | +$18.7M | 0.07% | 255 |
|
|
2026
Q1 | $303K | Sell |
5,001
-12
| -0.2% | -$700 | ﹤0.01% | 1141 |
|
|
2025
Q4 | $270K | Sell |
5,013
-74,775
| -94% | -$3.6M | ﹤0.01% | 1230 |
|
|
2025
Q3 | $3.6M | Buy |
79,788
+24,788
| +45% | +$1.16M | 0.02% | 597 |
|
|
2025
Q2 | $2.55M | Buy |
55,000
+12,610
| +30% | +$619K | 0.02% | 599 |
|
|
2025
Q1 | $2.59M | Sell |
42,390
-89,777
| -68% | -$5.23M | 0.02% | 603 |
|
|
2024
Q4 | $7.48M | Sell |
132,167
-127,795
| -49% | -$7.14M | 0.06% | 300 |
|
|
2024
Q3 | $13.5M | Buy |
+259,962
| New | +$12.2M | 0.11% | 166 |
|
|
2021
Q4 | – | Sell |
-6,265
| Closed | -$371K | – | 1158 |
|
|
2021
Q3 | $371K | Buy |
+6,265
| New | +$413K | ﹤0.01% | 846 |
|
|
2021
Q2 | – | Sell |
-13,559
| Closed | -$856K | – | 1132 |
|
|
2021
Q1 | $856K | Sell |
13,559
-4,294
| -24% | -$267K | 0.02% | 519 |
|
|
2020
Q4 | $1.11M | Sell |
17,853
-1,497
| -8% | -$92K | 0.02% | 270 |
|
|
2020
Q3 | $1.17M | Buy |
+19,350
| New | +$1.16M | 0.02% | 193 |
|
|
2020
Q2 | – | Sell |
-52,413
| Closed | -$2.85M | – | 600 |
|
|
2020
Q1 | $2.85M | Sell |
52,413
-14,748
| -22% | -$901K | 0.13% | 94 |
|
|
2019
Q4 | $4.31M | Buy |
+67,161
| New | +$3.85M | 0.01% | 86 |
|
|
2019
Q2 | – | Sell |
-181,042
| Closed | -$8.64M | – | 440 |
|
|
2019
Q1 | $8.64M | Buy |
+181,042
| New | +$9.02M | 0.44% | 41 |
|
|
2017
Q4 | – | Sell |
-7,308
| Closed | -$465K | – | 332 |
|
|
2017
Q3 | $465K | Buy |
+7,308
| New | +$427K | 0.05% | 193 |
|
|
2016
Q4 | – | Sell |
-16,683
| Closed | -$900K | – | 330 |
|
|
2016
Q3 | $900K | Sell |
16,683
-310
| -2% | -$19.9K | 0.09% | 205 |
|
|
2016
Q2 | $1.25M | Buy |
+16,993
| New | +$1.2M | 0.19% | 150 |
|
|
2016
Q1 | – | Sell |
-15,588
| Closed | -$1.07M | – | 378 |
|
|
2015
Q4 | $1.07M | Buy |
+15,588
| New | +$1.03M | 0.35% | 60 |
|
|
2015
Q3 | – | Sell |
-18,065
| Closed | -$1.2M | – | 328 |
|
|
2015
Q2 | $1.2M | Buy |
18,065
+12,865
| +247% | +$848K | 0.15% | 203 |
|
|
2015
Q1 | $335K | Sell |
5,200
-7,112
| -58% | -$445K | 0.05% | 327 |
|
|
2014
Q4 | $727K | Buy |
+12,312
| New | +$694K | 0.1% | 247 |
|
Other funds holding BMY
LMR Partners's BMY Position: Q2 2026 in Review
LMR Partners increased its Bristol-Myers Squibb (BMY) stake by 6,502% in Q2 2026, buying an estimated $18.7M and bringing the position to 330,151 shares worth $19M. The position accounts for 0.07% of the portfolio, ranked #255.
LMR Partners first reported a position in BMY in Q4 2014 and has held it in 22 quarters since. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- LMR Partners held 330,151 shares of Bristol-Myers Squibb worth $19M as of Q2 2026.
- LMR Partners bought 325,150 Bristol-Myers Squibb shares in Q2 2026, an estimated $18.7M.
- Bristol-Myers Squibb made up 0.07% of LMR Partners's portfolio in Q2 2026, its #255 holding.
- LMR Partners first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 22 quarters since.
- 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on LMR Partners's 13F filing for Q2 2026, filed 14 Aug 2026.